Ozogamicin
The term ozogamicin in the names of monoclonal antibodies or antibody-drug conjugates indicates that they are linked to a cytotoxic agent from the class of calicheamicins.[2]
Identifiers | |
---|---|
| |
CAS Number | |
UNII | |
Chemical and physical data | |
Formula | C73H97IN6O25S3 |
Molar mass | 1681.68 g·mol−1 |
3D model (JSmol) | |
| |
|
References
- "マイロターグ点滴静注用5mg インタビューフォーム" [Myrotarg 5mg for intravenous drip infusion interview form] (PDF). www.info.pmda.go.jp (in Japanese). Retrieved 2021-12-28.
- Jabbour E, Paul S, Kantarjian H (July 2021). "The clinical development of antibody-drug conjugates - lessons from leukaemia". Nature Reviews. Clinical Oncology. 18 (7): 418–433. doi:10.1038/s41571-021-00484-2. PMID 33758376. S2CID 232329035.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.